TEVA (Teva Pharmaceutical Industries) Dividend Payout Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TEVA Teva Pharmaceutical Industries Ltd TEVA
47 GF Score
Price $40.47
GF Value $18.61
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Teva Pharmaceutical Industries's Dividend Payout Ratio for the months ended in Jun. 2026 was .

The historical rank and industry rank for Teva Pharmaceutical Industries's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Teva Pharmaceutical Industries was 0.27. The lowest was 0.21. And the median was 0.24.

TEVA's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.38
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-09-21), the Dividend Yield % of Teva Pharmaceutical Industries is 0.00%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Teva Pharmaceutical Industries was 8.10%. The lowest was 0.00%. And the median was 3.21%.

Teva Pharmaceutical Industries's Dividends per Share for the months ended in Jun. 2026 was $0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Teva Pharmaceutical Industries was 73.90% per year. The lowest was -14.10% per year. And the median was 22.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Teva Pharmaceutical Industries (NYSE:TEVA) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Teva Pharmaceutical Industries Dividend Payout Ratio Related Terms

Teva Pharmaceutical Industries Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Teva Pharmaceutical Industries's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries Dividend Payout Ratio Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Teva Pharmaceutical Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -

TEVA vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Dividend Payout Ratio falls into.


TEVA
47GF Score
Teva Pharmaceutical Industries Ltd TEVA
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teva Pharmaceutical Industries Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Teva Pharmaceutical Industries's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0/ 2.3643525104955
=0.00

Teva Pharmaceutical Industries's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=0/ -0.27922009341295
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Teva Pharmaceutical Industries (TEVA) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of $40.47 is trading 117.4% above its estimated GF Value™ of $18.61. GuruFocus considers Teva Pharmaceutical Industries to be Significantly Overvalued.

Key valuation signals for TEVA:

  • Dividend Payout Ratio:
  • GF Value™: $18.61 vs. price of $40.47 (117.4% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the TEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
47GF Score

Get the complete analysis for TEVA

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.47
Price
$18.61
GF Value